Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription - PubMed (original) (raw)
Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription
Pei-Yun Chang et al. J Mol Biol. 2010.
Abstract
The MLL (mixed-lineage leukemia) proto-oncogene encodes a histone methyltransferase that creates the methylated histone H3K4 epigenetic marks, commonly associated with actively transcribed genes. In addition to its canonical histone methyltransferase SET domain, the MLL protein contains three plant homeodomain (PHD) fingers that are well conserved between species but whose potential roles and requirements for MLL function are unknown. Here, we demonstrate that the third PHD domain of MLL (PHD3) binds histone H3 trimethylated at lysine 4 (H3K4me3) with high affinity and specificity and H3K4me2 with 8-fold lower affinity. Biochemical and structural analyses using NMR and fluorescence spectroscopy identified key amino acids essential for the interaction with H3K4me3. Site-directed mutations of the residues involved in recognition of H3K4me3 compromised in vitro H3K4me3 binding but not in vivo localization of full-length MLL to chromatin sites in target promoters of MEIS1 and HOXA genes. Whereas intact PHD3 finger was necessary for MLL occupancy at these promoters, H3K4me3 binding was critical for MLL transcriptional activity. These results demonstrate that MLL occupancy and target gene activation can be functionally separated. Furthermore, these findings reveal that MLL not only "writes" the H3K4me3 mark but also binds the mark, and this binding is required for the transcriptional maintenance functions of MLL.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Figures
Figure 1. The MLL PHD3 finger binds histone H3K4me3
(A, B) Immuno-detection (anti-GST antibody) shows binding of GST-PHD3 to the indicated biotinylated histone peptides in a peptide pull-down assay (A) and peptide microarray (B). (C) Western blot using antibodies to the indicated epitopes shows binding of GST-PHD3 to a calf thymus histone mixture. (D, F) Shown are superimposed 1H, 15N HSQC spectra of 0.2 mM PHD3, collected while the indicated histone peptides were titrated in. The spectra are color-coded according to the peptide concentrations (inset). (E) The histogram displays normalized 1H, 15N chemical shift changes observed in backbone amides (or the side chain of W1594) in the corresponding (D) spectra of the PHD3 finger. Colored bars indicate significant change being greater than an average plus one-half standard deviation. Asterisk indicates loss of M1585 resonance.
Figure 2. Binding affinities of the MLL PHD3 finger
(A) Alignment of PHD domain sequences: zinc-coordinating and absolutely and moderately conserved residues are colored brown, blue and green, respectively. Residues of the MLL PHD3 finger that were mutated are marked with a black dot above the sequences and labeled. (B) Immuno-detection (anti-GST) shows binding of wt or mutant GST-PHD3 proteins indicated on the left to biotinylated histone peptides in a peptide pull-down assay. (C) Peptide microarray results are shown for binding of wt or mutant GST-PHD3 to the indicated biotinylated histone peptides. (D) The Kd values for interaction of wild type or mutant MLL PHD3 fingers with the indicated histone peptides were measured by tryptophan fluorescence (a) or NMR (b). (E) A representative binding curve used to determine Kds for wild type PHD3 by tryptophan fluorescence.
Figure 3. MLL PHD3-to-histone H3K4me3 association is not required for MLL occupancy on select gene loci
(A) Quantitative real-time PCR was used to analyze chromatin immunoprecipitation results in 293T cells expressing wild type or mutant MLL proteins. (B) MLL protein levels were analyzed by western blot analysis.
Figure 4. MLL PHD3-to-histone H3K4me3 association is critical for MLL dependent target gene expression
(A) Quantitative real-time RT-PCR was used to analyze gene expression levels in 293T cells expressing wild-type or mutant MLL proteins. (B) Model for MLL PHD3-mediated functions.
Similar articles
- Molecular mechanism of MLL PHD3 and RNA recognition by the Cyp33 RRM domain.
Hom RA, Chang PY, Roy S, Musselman CA, Glass KC, Selezneva AI, Gozani O, Ismagilov RF, Cleary ML, Kutateladze TG. Hom RA, et al. J Mol Biol. 2010 Jul 9;400(2):145-54. doi: 10.1016/j.jmb.2010.04.067. Epub 2010 May 8. J Mol Biol. 2010. PMID: 20460131 Free PMC article. - The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression.
Park S, Osmers U, Raman G, Schwantes RH, Diaz MO, Bushweller JH. Park S, et al. Biochemistry. 2010 Aug 10;49(31):6576-86. doi: 10.1021/bi1009387. Biochemistry. 2010. PMID: 20677832 Free PMC article. - Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.
Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, Patel DJ. Li H, et al. Nature. 2006 Jul 6;442(7098):91-5. doi: 10.1038/nature04802. Epub 2006 May 21. Nature. 2006. PMID: 16728978 Free PMC article. - Mixed lineage leukemia: a structure-function perspective of the MLL1 protein.
Cosgrove MS, Patel A. Cosgrove MS, et al. FEBS J. 2010 Apr;277(8):1832-42. doi: 10.1111/j.1742-4658.2010.07609.x. Epub 2010 Mar 4. FEBS J. 2010. PMID: 20236310 Free PMC article. Review. - The molecular biology of mixed lineage leukemia.
Slany RK. Slany RK. Haematologica. 2009 Jul;94(7):984-93. doi: 10.3324/haematol.2008.002436. Epub 2009 Jun 16. Haematologica. 2009. PMID: 19535349 Free PMC article. Review.
Cited by
- Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.
Ballabio E, Milne TA. Ballabio E, et al. Cancers (Basel). 2012 Sep 10;4(3):904-44. doi: 10.3390/cancers4030904. Cancers (Basel). 2012. PMID: 24213472 Free PMC article. - Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex.
Jamali M, Barar E, Shi J. Jamali M, et al. Int J Mol Sci. 2024 May 7;25(10):5069. doi: 10.3390/ijms25105069. Int J Mol Sci. 2024. PMID: 38791111 Free PMC article. Review. - RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription.
Blatter M, Meylan C, Cléry A, Giambruno R, Nikolaev Y, Heidecker M, Solanki JA, Diaz MO, Gabellini D, Allain FH. Blatter M, et al. Sci Adv. 2023 Apr 21;9(16):eadf5330. doi: 10.1126/sciadv.adf5330. Epub 2023 Apr 19. Sci Adv. 2023. PMID: 37075125 Free PMC article. - A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.
Wang J, Muntean AG, Wu L, Hess JL. Wang J, et al. J Biol Chem. 2012 Dec 21;287(52):43410-6. doi: 10.1074/jbc.M112.423855. Epub 2012 Nov 5. J Biol Chem. 2012. PMID: 23129768 Free PMC article. - TrxG and PcG proteins but not methylated histones remain associated with DNA through replication.
Petruk S, Sedkov Y, Johnston DM, Hodgson JW, Black KL, Kovermann SK, Beck S, Canaani E, Brock HW, Mazo A. Petruk S, et al. Cell. 2012 Aug 31;150(5):922-33. doi: 10.1016/j.cell.2012.06.046. Epub 2012 Aug 23. Cell. 2012. PMID: 22921915 Free PMC article.
References
- David Allis C, Danny Reinberg TJ. Marie-Laure Caparros. Epigenetics
- Slany RK. When epigenetics kills: MLL fusion proteins in leukemia. Hematol Oncol. 2005;23:1–9. - PubMed
- Sutherland HG, Mumford GK, Newton K, Ford LV, Farrall R, Dellaire G, Caceres JF, Bickmore WA. Large-scale identification of mammalian proteins localized to nuclear sub-compartments. Hum Mol Genet. 2001;10:1995–2011. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA113472/CA/NCI NIH HHS/United States
- R01 CA113472/CA/NCI NIH HHS/United States
- R01 CA116606-05/CA/NCI NIH HHS/United States
- R01 CA116606/CA/NCI NIH HHS/United States
- CA55029/CA/NCI NIH HHS/United States
- R01 CA055029-18/CA/NCI NIH HHS/United States
- CA116606/CA/NCI NIH HHS/United States
- GM079641/GM/NIGMS NIH HHS/United States
- R01 CA116606-07/CA/NCI NIH HHS/United States
- R01 CA055029/CA/NCI NIH HHS/United States
- R01 GM079641/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases